POT1 inhibitors belong to a distinctive chemical class of compounds that are specifically designed to modulate the activity of the protection of telomeres 1 (POT1) protein. The POT1 protein is a vital component of telomere protection and maintenance in eukaryotic cells. Telomeres are repetitive DNA sequences located at the ends of linear chromosomes that play a crucial role in preserving genomic stability by preventing the degradation and fusion of chromosome ends. POT1, in particular, is known for its role in preventing the activation of DNA damage response mechanisms at telomeres and safeguarding them from being recognized as double-strand breaks. POT1 inhibitors are meticulously developed to interact with the POT1 protein, disrupting its normal function in binding to telomeric DNA. By inhibiting the interaction between POT1 and telomeric DNA, these compounds potentially induce telomere dysfunction or aberrant telomere length regulation. The chemical structures of POT1 inhibitors are tailored to facilitate their binding to the POT1 protein's active sites, often through the identification of key structural motifs that allow for effective inhibition.
Researchers often employ a combination of computational modeling, high-throughput screening, and structural studies to design and optimize POT1 inhibitors. The goal is to create compounds with high selectivity for POT1 and minimal off-target effects on other cellular components. The development of POT1 inhibitors not only expands our understanding of telomere biology and the intricate mechanisms governing telomere protection but also provides valuable tools for probing the consequences of telomere dysfunction in various biological contexts. These compounds serve as critical instruments in deciphering the intricate roles of POT1 in cellular processes and potentially open up avenues for novel research directions in cellular biology and genetics.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Piperlongumine | 20069-09-4 | sc-364128 | 10 mg | $107.00 | ||
This compound is found in the long pepper plant and has shown potential as a POT1 inhibitor. It is being studied for its anti-cancer properties. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $158.00 | 6 | |
Found in the roots of the thunder god vine, celastrol has demonstrated inhibitory effects on the proteasome, including POTIt has been researched for its potential in various diseases, including cancer and neurodegenerative disorders. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
Found in the Indian herb Ashwagandha, withaferin A has shown anti-cancer properties and has been investigated as a proteasome inhibitor, including its impact on POT1. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a compound found in green tea that has been studied for its various health benefits. It has been explored as a potential proteasome inhibitor, including effects on POT1. | ||||||
Carfilzomib | 868540-17-4 | sc-396755 | 5 mg | $41.00 | ||
It belongs to a class of chemicals called proteasome inhibitors and could have an effect on POT1 activity. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor that is commonly studied in a laboratory setting for potential use in multiple myeloma and some other types of cancer. | ||||||
Delanzomib, free base | 847499-27-8 | sc-396774 sc-396774A | 5 mg 10 mg | $160.00 $300.00 | ||
Also known as CEP-18770, delanzomib is an investigational proteasome inhibitor | ||||||
ONX 0914 | 960374-59-8 | sc-477437 | 5 mg | $245.00 | ||
This compound is being studied for its selective inhibitory effects on the immunoproteasome, which is a variant of the proteasome. It could potentially impact POT1 as well. | ||||||